Navigation Links
AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
Date:5/2/2013

d-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the ability of AcelRx Pharmaceuticals to successfully complete the clinical trials for the sufentanil NanoTab System, that fact that subsequent analyses of the data may lead to different (including less favorable) interpretations of the results than the analyses conducted to date, or be subject to differing interpretations by the regulatory agencies; the success, cost and timing of all product development activities and clinical trials; the uncertain clinical development process, including the risk that clinical trials, have an effective design, or be completed on schedule; any delays or inability to obtain and maintain regulatory approval of its product candidates in the United States and Europe; its ability to attract funding partners or collaborators with development, regulatory and commercialization expertise; its ability to obtain sufficient financing to complete registration of its product candidates in the United States and Europe; the market potential for its product candidates; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' U.S. Securities and Exchange Commission filings and reports, including its Annual Report on Form 10-K filed with the SEC on March 12, 2013.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

(Logo: http://photos.prnewswire.com/prnh/20130226/MM67303LOGO)


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
2. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
3. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
4. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
5. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. AcelRx Pharmaceuticals Provides Clinical Trial Updates
7. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
8. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
10. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
11. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 Stand Up To Cancer ... of a $20 million Dream Team to attack the number ... the Annual Meeting of the American Association for Cancer Research ... that 221,000 people in the United States ... 2015, and 158,040 will die from it, making lung cancer ...
(Date:4/20/2015)... 20, 2015 Kalorama Information says that ... to be robust; the market is driven by ... global markets, new product innovations and increasing life ... market inhibitors, such as government restraints, limited hospital ... The healthcare market research publisher,s report, Insulin ...
(Date:4/20/2015)... INDIANAPOLIS , April 20, 2015 Eli ... that the investigational medicine ixekizumab was statistically superior to ... arthritis (PsA), as demonstrated by the proportion of patients ... standard assessment that represents a 20 percent reduction in ... College of Rheumatology response criteria. During the 24-week, Phase ...
Breaking Medicine Technology:New SU2C-American Cancer Society Lung Cancer Dream Team Announced 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 4New SU2C-American Cancer Society Lung Cancer Dream Team Announced 5New SU2C-American Cancer Society Lung Cancer Dream Team Announced 6Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... 7 With the growth in the home health care ... Entertainment 2009® that it is offering OnCare by Xora, an ... helps address the specific needs of mobile health care workers ... , Designed specifically for use by home caregivers who travel ...
... Oct. 7 Odyssey Thera, Inc. announced that it ... Pfizer Inc. following Pfizer,s decision to progress drug candidates ... alliance with Pfizer announced in August, 2006. These milestones ... for the advancement of specific drug candidates, and follow ...
Cached Medicine Technology:Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 2
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has trained ... school in Byfield, MA. Applications are being accepted for ... grades 6-12. , The outstanding professional, college, and high ... , Offensive and defensive linemen and linebackers ... most unsung positions on the field, the the success ...
(Date:4/21/2015)... 2015 Freeslate, Inc ., the ... today announced that the Centre for Catalysis Research ... has acquired a Freeslate Core Module 3 (CM3) ... (SPR) to accelerate current research programs. The systems ... they will be available to academic users and industrial ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 This ... pathologists, physical therapist assistants, occupational therapist assistants, teachers, ... and techniques to help children across the autism ... through Education Resources Inc. , ... 2008, this highly acclaimed yoga curriculum addresses learning ...
(Date:4/20/2015)... Draft, Virginia (PRWEB) April 20, 2015 ... Augusta Health facility in Stuarts Draft, an independent, ... County, Staunton, and Waynesboro, Virginia. The project was ... Architects. The Stuarts Draft facility is expected to ... , Located on Stuarts Draft Highway, the new ...
(Date:4/20/2015)... April 21, 2015 The National ... Binau, Founder of Soul Care Group, Inc., as ... is recognized with this prestigious distinction for leadership in ... Local Chapters, NAPW is the nation's leading networking organizaiton ... Susan with our Woman of the Year Award,” says ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:National Association of Professional Women Announces Susan Binau, Founder of Soul Care Group, Inc., a 2015 Professional Woman of the Year 2
... Stabilized ... ENADH NADH, ... and distributor of nadh branded nutritional products, has,obtained the exclusive distribution ... the USA. ENADA,NADH was the original nadh product, stabilized by Prof. ...
... Breathing,Resistance Exerciser has been selected as the ... L.A. Times. Jorge Brouwer, inventor of the ... the easy,to use "Expand-A-Lung.", *(PHOTO ... Resistance Exerciser.) When asked about how ...
... Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical ... vaccine at the 6th Congress of Medical Microbiology ... presentation was made by Dr. Dragan,Rogan, Vice-President, Bioniche ... vaccine is the world,s first vaccine that may ...
... June 17 For women about to give,birth, one ... ensuring they have on,hand the right music., (Photo: ... studies have found that music can reduce,anxiety and stress ... "There,s a lot of pain and discomfort that can ...
... Research in the United States has shown that obese people ... for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell ... Medicine & Dentistry, have undertaken a study to see if ... obesity is associated with higher rates of some types of ...
... ,lack of motivation, ,lack of money, and ,lack of time, as, ... ... health, SANTA MONICA, Calif., June 17 Findings from a ... to improve their overall health, but less than half of those ...
Cached Medicine News:Health News:ENADA NADH Is Back 2Health News:Have You Exercised Your Lungs Today? 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 3Health News:Using Music to Ease the Pain of Labor; New CD Featuring Celine Dion, Norah Jones, Provides Soothing Songs for Delivery 2Health News:Obese women in Canada are less likely to be screened for cervical cancer 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 3Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: